(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Patterson Cos' Strong Q4 Earnings and Intel's Strategic Sale Shake the Market

June 21st, 2023

Patterson Companies, Inc. (Nasdaq: PDCO), a leading provider of products and services to the dental, animal health, and rehabilitation markets, announced strong fourth-quarter fiscal 2023 earnings. The company reported earnings per share (EPS) of $0.. Read more

Winnebago: Earnings Beat, Revenues Miss; Chemomab's Liver Fibrosis Trial Data Sparks Surge

June 21st, 2023

Winnebago Industries, Inc. (NYSE: WGO), a well-known manufacturer of recreational vehicles and marine products, reported adjusted earnings per share (EPS) of $2.13 for its its third-quarter fiscal 2023, surpassing the consensus estimate of $1.83. . Read more

Medical Breakthroughs: argenx's VYVGART Hytrulo and Pfizer's TALZENNA Garner FDA Approval

June 21st, 2023

argenx SE (Nasdaq: ARGX) has received approval from the U.S. Food and Drug Administration (FDA) for VYVGART Hytrulo, a subcutaneous injection used to treat generalized myasthenia gravis (gMG) in adult patients who test positive for anti-acetylcholine. Read more

Major Breakthrough: RTX's $1.15B+ Contract, LumiraDx Soars with UK's MHRA Validation

June 20th, 2023

Raytheon Missiles & Defense, a business segment of RTX (NYSE: RTX), has been awarded a significant contract worth $1,151,111,454 for the production of Advanced Medium Range Air-to-Air Missiles (AMRAAM). The contract also includes the provision of AMR. Read more

PureCycle Making Waves with Successful UPR Resin Production; La-Z-Boy's Sales Outlook Falls Short

June 20th, 2023

Shares of PureCycle Technologies, Inc. (Nasdaq: PCT) experienced a significant surge of over 10% in after-hours trading Tuesday following the successful production of the first run of Ultra-Pure Recycled (UPR) resin from post-industrial recycled mate. Read more

SEC Charges Stanley Black & Decker and Former Executive for Failures in Executive Perks Disclosure

June 20th, 2023

Company’s self-reporting and additional cooperation result in partial declination of charges and no civil penalty FOR IMMEDIATE RELEASE 2023-111 Washington D.C. / CRWE PRESS RELEASE / June 20, 2023  — The Securities and Exchan. Read more

Momentum Shift: MiMedx's Strategic Reorganization, FedEx's Q4 Earnings Figures

June 20th, 2023

MiMedx Group, Inc. (Nasdaq: MDXG) has announced a strategic realignment aimed at prioritizing the growth of its Wound & Surgical business.  This realignment involves the immediate suspension of its Knee Osteoarthritis program and the disbandi. Read more

Nuwellis and DaVita Strike Deal, Rivian Secures Tesla's Supercharger Network Access

June 20th, 2023

Nuwellis, Inc. (Nasdaq: NUWE) has partnered with DaVita Inc. (NYSE: DVA) through a Supply and Collaboration Agreement to introduce Aquadex ultrafiltration therapy for the treatment of adult patients with congestive heart failure in select U.S. market. Read more

Buy Ratings: PM, ATMU, CALT, USAU, COHR, MAN, AJG - Potential Upsides Unveiled

June 20th, 2023

Philip Morris International Inc. (NYSE: PM), a global tobacco company, was upgraded from Neutral to Buy by Citigroup, with the price target raised from $109 to $117.  On Friday, $PM closed at $94.89, indicating a potential upside of $22.11 or. Read more

Breaking: Sanofi's Legal Win, Innovative Eyewear's License Deal

June 20th, 2023

Shares of Sanofi (Nasdaq: SNY) surged in pre-market trading following the announcement of a favorable outcome in an International Chamber of Commerce dispute.  The tribunal ruled in favor of Sanofi, dismissing Boehringer Ingelheim's. Read more